載入...

A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321

INTRODUCTION: Despite the advances in radiation techniques and chemotherapy, survival with current platinum-based chemotherapy and concomitant thoracic radiation remains dismal. Bortezomib, a proteasome inhibitor, modulates apoptosis and cell cycle through disruption of protein degradation. The comb...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Thorac Oncol
Main Authors: Zhao, Yujie, Foster, Nathan R., Meyers, Jeffrey P., Thomas, Sachdev P., Northfelt, Donald W., Rowland, Kendrith M., Mattar, Bassam I., Johnson, David B., Molina, Julian R., Mandrekar, Sumithra J., Schild, Steven E., Bearden, James D., Aubry, Marie-Christine, Adjei, Alex A.
格式: Artigo
語言:Inglês
出版: 2015
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320011/
https://ncbi.nlm.nih.gov/pubmed/25247339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000383
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!